HealthQuill Investment
Amgen Inc., a US biotechnology company, will set up a second drug manufacturing facility in North Carolina for $1 billion, according to a company statement.
Drugs Medical Pharma

Amgen Inc., to invest $1 billion to build a second plant in North Carolina

Amgen Inc., a US biotechnology company, will set up a second drug manufacturing facility in North Carolina for $1 billion, according to a.

Read More
Britain's AstraZeneca will invest $3.5 billion in the US, its largest market, to expand its research and manufacturing footprint by the end of 2026, according to a company statement.
Drugs Health Pharma

AstraZeneca to invest $3.5 billion in the US to expand global footprint

Britain's AstraZeneca will invest $3.5 billion in the US, its largest market, to expand its research and manufacturing footprint by the end of.

Read More
Eli Lilly and Company will invest one billion dollars to expand its facility in Ireland to increase its production of drugs to treat Alzheimer’s disease, diabetes and obesity, according to a company statement.
Drugs Health Pharma

Eli Lilly to invest $1b in Irish facility to make Alzheimer’s, obesity drugs

Eli Lilly and Company will invest one billion dollars to expand its facility in Ireland to increase its production of drugs to treat.

Read More
— at a time when President Emmanuel Macron is taking steps to stem the country’s industrial decline.
Drugs Health Pharma

Novo Nordisk invests $2.3b in France for diabetes, obesity drugs

HQ Team November 23, 2023: Novo Nordisk will invest $2.3 billion to expand production of its weight-loss and diabetes drug in Chartes, France..

Read More
Nvidia has invested $50 million in a clinical-stage biotechnology company, Recursion, to speed up the development of artificial intelligence models for drug recovery and may later license them, according to a statement.
Drugs Health Pharma

Nvidia invests $50 million in Recursion to hasten AI drug recovery

HQ Team July 12, 2023: Nvidia has invested $50 million in a clinical-stage biotechnology company, Recursion, to speed up the development of artificial.

Read More